Chemed Corporation
CHE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8 | $9 | $8 | $8 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $8 | $9 | $8 | $9 |
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 7.4% | 6.1% | -0.2% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 35.1% | 35.3% | 35.8% | 36% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 19.1% | 18.3% | 18.4% | 19.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 12.4% | 12% | 11.7% | 12.6% |
| EPS Diluted | 19.89 | 17.93 | 16.53 | 16.85 |
| % Growth | 10.9% | 8.5% | -1.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |